Publications by authors named "Robert Cuffe"

Claim this Profile
H
HIV prevention trial design in an era of effective pre-exposure prophylaxis.
Amy Cutrell, Deborah Donnell, David T Dunn, David V Glidden, Anneke Grobler, Robert L Cuffe

HIV Clin Trials· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Missing CD4+ cell response in randomized clinical trials of maraviroc and dolutegravir.
Robert Cuffe, Carly Barnett, Catherine Granier, Mitsuaki Machida, Cunshan Wang

HIV Clin Trials· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
When is a seamless study desirable? Case studies from different pharmaceutical sponsors.
Robert L Cuffe, David Lawrence, Andrew Stone, Marc Vandemeulebroecke

Pharm Stat· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
4
48-week efficacy and safety of dolutegravir relative to commonly used third agents in treatment-naive HIV-1-infected patients: a systematic review and network meta-analysis.
Dipen A Patel, Sonya J Snedecor, Wing Yu Tang, Lavanya Sudharshan, Jessica W Lim, Robert Cuffe

PLoS One· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dolutegravir efficacy at 48 weeks in key subgroups of treatment-naive HIV-infected individuals in three randomized trials.
François Raffi, Anita Rachlis, Cynthia Brinson, Keikawus Arasteh, Miguel Górgolas, Robert Liam Cuffe

AIDS· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalent polymorphisms in wild-type HIV-1 integrase are unlikely to engender drug resistance to dolutegravir (S/GSK1349572).
Cindy Vavro, Samiul Hasan, Heather Madsen, Joseph Horton, Felix DeAnda, Robert Cuffe

Antimicrob Agents Chemother· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The statistician's role in the prevention of missing data.
Sara Hughes, Julia Harris, Nancy Flack, Robert L Cuffe

Pharm Stat· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjusting for covariates in non-inferiority studies with margins defined as risk differences.
Khadeeja Mohamed, Andrew Embleton, Robert L Cuffe

Pharm Stat· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The inclusion of historical control data may reduce the power of a confirmatory study.
Robert L Cuffe

Stat Med· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A study of HIV provider attitudes toward HLA-B 5701 testing in the United States.
Maria E Watson, Lisa G Patel, Belinda Ha, Paul Wannamaker, Robert Cuffe

AIDS Patient Care STDS· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Informing the selection of futility stopping thresholds: case study from a late-phase clinical trial.
Sara Hughes, Robert L Cuffe, Alfons Lieftucht, W Garrett Nichols

Pharm Stat· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Medium-term variability of blood pressure and potential underdiagnosis of hypertension in patients with previous transient ischemic attack or minor stroke.
Robert L Cuffe, Sally C Howard, Ale Algra, Charles P Warlow, Peter M Rothwell

Stroke· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis